Trending:
May 10, 2024, 10:53 AM - 2 min read
The AIM urged the government of India to compensate all the victims of COVID-19 vaccines, including their family members, through a mechanism that also involves vaccine manufacturers.
Read more
May 2, 2024, 09:34 AM - 2 min read
AstraZeneca, a British pharmaceutical company, has admitted in a UK court that its vaccine, which is sold in India under the name Covishield, can cause a rare side effect related to blood clotting called TTS.
Read more
April 30, 2024, 12:08 PM - 2 min read
Prime Minister Narendra Modi flagged off India’s mass Covid-19 vaccination drive with two vaccines - Serum Institute of India’s (SII) Covishield and Bharat Biotech’s homegrown vaccine Covaxin - which were approved by the country's drugs regulator earlier in January 2021.
Read more